We have been trusted advisors to the world’s most innovative bio-business, and like to continue our growth with the help of supportive global network
Employees
1
Locations
1
Clients
1
14
years of learning mapping drug development innovations
Established in 2010 as a subsidiary of HH BioTechnologies Pvt. Ltd., OmicsX was founded with a unique objective: to collect and map emerging cancer drug targets. This vital information supports our parent company’s pioneering work in Cancer Systems Biology.
In our earlier days, we work to design and publish NSCLC Gene Regulatory Networks, utilizing high-throughput omics data from lung cancer patients. Through our innovative research, we have identified three previously unexplored cancer drug targets, reinforcing our commitment to advancing cancer treatment and research.
During our journey, we recognized a significant gap between scientific discoveries, people, and events and found all were not mapped comprehensively enough to predict future trends in a holistic manner. A systems-based approach, both scientifically and managerially, is essential to carefully map individual events, providing insights to avoid failures and nurture future bio-entrepreneurs.
Since 2012, we have been closely monitoring and mapping scientific and business activities for the largest number of active drug developers worldwide, along with an equally significant number of clinical research companies supporting them. Our efforts are focused on generating holistic knowledge designed to accelerate innovation and reduce risks.
In 2013, we published our first commercial report, “Oncology Drug Intelligence,” which provides comprehensive knowledge and was highly appreciated for offering a holistic view on cancer drug discovery. Additionally, we released our first extensive “ Cancer Research Funding Report,” available for free download, further contributing to the scientific community.
In 2021, leveraging our accumulated knowledge, we began actively designing robust solutions to Connect Innovations, aiming to make breakthroughs faster and less risky. At OmicsX, we are dedicated to driving progress in the field of drug discovery and development.
who we are
We are a team of like-minded people, with an aims to create perfectly crafted ready to implement drug discovery market intelligence solutions. We value honest approach to business and praise fair-play attitude from all parties. We as a team works together and understand our clients business needs clearly and quickly!
our mission Is to create Human Derived Solutions which will help in speeding the innovations.
CONNECTING
SMART PEOPLE
Solutions Helping Bio-Innovators to Quickly Identify and Connect
CHAOS TO CREATIVITY
Developing Online Platforms to simplify Networking among Bio-innovators.
Amit Gupta
Founder
Vast entrepreneurial experience of 16+ years, in establishing and successfully running innovation driven biotechnology companies. As a first generation entrepreneur always eager to take risk and challenges in any direction which have a potential of changing some face of tomorrow’s world.
Till yet established three companies all working in different domain from manufacturing, innovations to service providing domain, with only one focus, how to make things profitable in biological science. Hard worker and always learner in field of biological science.
A. Gupta
